1
Registration No. 333-17259
As filed with the Securities and Exchange Commission on July 24, 1998
-----------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------------
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
-----------------------------
DURAMED PHARMACEUTICALS, INC.
(Exact name of issuer as specified in its charter)
Delaware 11-2590026
------------------------ ----------------------------------
(State of Incorporation) (I.R.S. Employer Identification No.)
7155 East Kemper Road, Cincinnati, Ohio 45249
-----------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
1988 STOCK OPTION PLAN
(Full Title of the Plan)
Timothy E. Hoberg, Esq.
Taft, Stettinius & Hollister
1800 Star Bank Center
Cincinnati, Ohio 45202
(Name and address of agent for service)
Telephone number, including area code,
of agent for service: (513) 381-2838
2
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Explanatory Statement
As originally filed in December 1996, this Registration Statement
registered 2,000,000 additional shares of the Common Stock of Duramed
Pharmaceuticals, Inc. (the "Company") which had been approved for issuance under
the Company's 1988 Stock Option Plan (the "1988 Plan"). Subsequently, the
Company adopted a new plan, the 1997 Stock Option Plan (the "1997 Plan"), with
the understanding that shares remaining available for option grant under the
1988 Plan would be transferred to the 1997 Plan.
Accordingly, this Post-Effective Amendment is being filed to
de-register 770,275 shares previously registered for the 1988 Plan and to move
those shares to a new Form S-8 Registration Statement being filed by the Company
for shares issuable under the 1997 Plan.
II-1
3
SIGNATURES
The Registrant. Pursuant to the requirements of the Securities Act
of 1933, as amended, the registrant certifies that it has reasonable grounds to
believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Post-Effective Amendment to the Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City
of Cincinnati, State of Ohio as of the 23rd day of July, 1998.
DURAMED PHARMACEUTICALS, INC.
By /s/ E. Thomas Arington
------------------------------
E. Thomas Arington, President
and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, as
amended, this Post- Effective Amendment to the Registration Statement has been
signed by the following persons in the capacities indicated as of the 23rd day
of July, 1998.
Signature Title
--------- -----
/s/ E. Thomas Arington Chairman of the Board,
- -------------------------- President and Chief Executive Officer (principal
E. Thomas Arington executive officer)
/s/ Timothy J. Holt Senior Vice-President - Finance
- -------------------------- and Administration, Treasurer (principal financial
Timothy J. Holt and accounting officer)
/s/ George W. Baughman* Director
- --------------------------
George W. Baughman
/s/ Stanley L. Morgan* Director
- --------------------------
Stanley L. Morgan
/s/ S. Sundararaman* Director
- --------------------------
S. Sundararaman
*Pursuant to Power of Attorney
/s/ Timothy J. Holt
- --------------------------
Timothy J. Holt
Attorney-in-Fact
II-2